Business Context and Reporting Period
This Form 8-K was filed by Greatbatch, Inc. on September 17, 2015, under Item 7.01 (Regulation FD Disclosure). The filing details the financing structure for the proposed acquisition of Lake Region Medical Holdings, Inc. ("Lake Region") and provides pro forma financial metrics for the combined entity. The filing also references a planned spin-off of the QiG Group subsidiary.
Key Financial Metrics
The filing provides specific pro forma Adjusted EBITDA figures and debt financing commitments but does not report historical revenue, net profit, or cash flow for Greatbatch, Inc. in this document.
- Pro Forma Adjusted EBITDA: Approximately $330 million for the twelve months ended July 3, 2015.
- Greatbatch Adjusted EBITDA: Approximately $162 million for the twelve months ended July 3, 2015.
- Lake Region Adjusted EBITDA: Approximately $143 million for the twelve months ended July 4, 2015 (adjusted downward from prior announcements due to due diligence findings).
- Projected Synergies: $25 million in year one pre-tax operating synergies.
- Debt Financing Structure:
- $300 million senior secured term loan A facility.
- $1.025 billion senior secured term loan B facility (increased from $1.0 billion).
- $200 million senior secured revolving facility.
- $400 million senior unsecured bridge loan facility (subject to reduction by long-term debt issuance).
- Spin-off Capital Contribution: Approximately $75 million cash contribution to QiG Group prior to the spin-off.
Material Changes
Greatbatch Ltd. has increased the proposed aggregate principal amount of the Term Loan B Facility to $1,025 million on a non-committed basis. Additionally, the company expects to seek $435 million in long-term debt financing to replace a portion or all of the drawings under the Bridge Facility. Lake Region's Adjusted EBITDA was revised downward to reflect expenses identified during due diligence.
Guidance, Outlook, and Risks
Management expects to close the Merger and the Spin-off, subject to market conditions and regulatory approvals. The filing includes extensive forward-looking statements regarding the benefits of the merger, integration plans, and future financial results.
Key Risks and Contingencies:
- Failure to realize anticipated synergies or benefits within expected timeframes.
- Inability to obtain necessary regulatory or antitrust approvals.
- Challenges in integrating operations, products, and employees.
- Disruption of management attention and relationships with customers or vendors.
- Access to financing on reasonable terms.
- General business risks including customer concentration, product obsolescence, and healthcare regulatory changes.
Investor Verification Checklist
- Verify the final terms of the $1.025 billion Term Loan B Facility and the extent of the Bridge Facility replacement with long-term debt.
- Confirm the final amount of the $75 million capital contribution to QiG Group prior to the spin-off.
- Review the detailed financial statements of Accellent Inc. (Lake Region's subsidiary) attached as Exhibits 99.1 and 99.2.
- Monitor regulatory approval status for the Lake Region acquisition.
- Assess the realization of the $25 million in projected year-one synergies post-closing.